Network News

Partnership Between Heidelberg and Harvard: Implementation of Initial Projects Begins

23 joint initiatives selected for funding – focus on long-term cooperation The strategic partnership between Heidelberg University and Harvard University is now seeing the launch of the first joint projects by researchers from the two institutions. In August 2025, their respective leading representatives had signed a Memorandum of Understanding in order to broaden the existing […]

Award for Heidelberg Evolutionary Geneticist

Henrik Kaessmann receives Ernst Schering Prize for fundamental contributions to understanding mammalian evolution Prof. Dr Henrik Kaessmann has been selected to receive the 2026 Ernst Schering Prize for his pioneering research into the evolutionary origins and genetic regulation of organ development and organ function. The award, which comes with 50,000 euros in prize money, is […]

VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement

VERAXA Biotech has strengthened its financial position to support the closing of its business combination with Voyager Acquisition Corp. and support advancement of its pipeline of BiTAC-TCE and BiTAC-ADC programs toward clinical development and through initial value inflection points. ZURICH, SWITZERLAND – May 28, 2026 – VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel […]

Professor Dr. Hanns-Peter Knaebel has been appointed Director of Medicine at the Heidelberg and Mannheim University Hospitals Network

Effective June 1, 2026, the Supervisory Board has appointed Hanns-Peter Knaebel, Chairman of the Executive Board, to serve as Chief Medical Officer. This move will ensure that the dynamic phase of medical strategy development and transformation within the group is overseen and managed centrally by the full Executive Board. Full Text in German below. Professor […]

ProtaGene Announces Strategic Partnership with the Life Science business of Merck to Expand Comprehensive Biologics Testing Solutions

HEILBRONN, Germany, May 14, 2026 – ProtaGene today announced a strategic partnership with the Life Science business of Merck, which operates as MilliporeSigma in the United States and Canada, to provide biopharmaceutical customers with an end-to-end testing solution across the entire biopharmaceutical product lifecycle, from early-stage development through GMP release testing. ProtaGene’s expertise in advanced protein […]

Universität Heidelberg Successful with Application for Collaborative Research Centre

DFG funds extended CRC with approximately 17.4 million euros Heidelberg University has been successful in the latest approval round of the German Research Foundation (DFG) with a grant application for a major research consortium: The Collaborative Research Centre “Molecular Circuits of Heart Disease” (CRC 1550), based at the Medical Faculty Heidelberg, is entering a second […]

HI-TAC: Karina Yaniv Appointed as New Scientific Director

Helmholtz Institute for Translational AngioCardioScience brings together expertise in cardiac, vascular and systems biology Prof. Dr Karina Yaniv of the Weizmann Institute of Science has been appointed as new Scientific Director of the Helmholtz Institute for Translational AngioCardioScience in Mannheim/Heidelberg (HI-TAC), the Max Delbrück Center in Berlin and Heidelberg University announced in cooperation with the […]

The Plasticity of Malignant Brain Tumors as a Potential Therapeutic Approach: Sibylle Assmus Prize for Neuro-Oncology Awarded to Moritz Mall

The ability of cancer cells to change their identity makes tumors such as glioblastoma particularly aggressive and resistant to treatment. Moritz Mall, of the German Cancer Research Center (DKFZ) and the Hector Institute for Translational Brain Research (HITBR), is investigating how this plasticity can be specifically restricted. His approach focuses on genetic “guardians” that suppress […]

Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved

Basel, Switzerland, 8 May 2026 – Today, Lonza Group Ltd held its Annual General Meeting (AGM), led by the Chair of the Board of Directors, Jean-Marc Huët. 62.58% of the share capital was represented at the AGM, with attending and represented shareholders collectively holding a total of 43,948,027 shares. All Board members standing for re-election were re-elected, each for a further term in office until the completion of the AGM 2027. The following Board members stood for re-election: Jean-Marc Huët, Juan […]